Asthma Medications - FOI Response Register

1. How many patients have been treated (for any condition) in the last 4 months with:

•           Benralizumab  - < 5

•           Dupilumab – SIX

•           Omalizumab  - < 5

•           Reslizumab – ZERO

•           Mepolizumab – < 5

•           Tezepelumab – < 5

Where we have given < 5 answers this is because NHS Shetland considers that providing more specific information carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38 (1) (b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.

2. Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age-groups:

•           Age 6-11 ZERO

•           Age 12-17 < 5

•           Age 18 and above TWELVE